CLINICAL_TRIALS
ClinicalTrials.gov record with results posted
A Phase 1/2 Open-Label Multiple Ascending Dose Study of INZ-701 With a Long-Term Extension in Adults With ABCC6 Deficiency Manifesting as Pseudoxanthoma Elasticum (PXE)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05030831
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-10-14T00:02:39.203350+00:00
- Published At
- 2026-10-13T00:00:00+00:00
- Record Updated At
- 2026-10-13
- Results Posted At
- 2026-10-13
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["ATP-Binding Cassette Subfamily C Member 6 Deficiency", "Pseudoxanthoma Elasticum", "Generalized Arterial Calcification of Infancy"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-10-13"- protocolSection.identificationModule.nctId
"NCT05030831"- protocolSection.identificationModule.officialTitle
"A Phase 1/2 Open-Label Multiple Ascending Dose Study of INZ-701 With a Long-Term Extension in Adults With ABCC6 Deficiency Manifesting as Pseudoxanthoma Elasticum (PXE)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-10-13"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.